Skip navigation

Latest Policies and Reform Initiatives Impacting Pricing, Strategy, Quality and Transparency

February 25-26, 2020
  • Alexandria, VA

The current Medicare and drug pricing landscape is facing the potential for seismic changes in the year ahead. CBI’s Medicare Pricing & Contracting Congress expands to convene stakeholders representing bio/pharma manufacturers, health plans, PBMs and leading policy advisors to provide critical updates and analysis on the impact of changing legislation. This conference provides in-depth analyses on critical topics including the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, Senate HELP Committee’s health care costs package, drug pricing bills, operationalizing value-based contracting, changes to the coverage gap and updates on the potential impacts of the International Pricing Index Model and the Most Favored-Nations Clause.

In-Depth Discussions on
High-Impact Issues, Including:

  • Political and legislative trends impacting coverage & access
  • International Pricing Index Model (IPI) and
    Most Favored-Nations Clause updates
  • Changes to Part B and ASP reporting requirements
  • Trends and insights into Medicare Part D drug spending
  • Key considerations for balancing care and quality
    while delivering patient-centric outcomes
  • Approaches for value-based contracting and
    alternative payment models

PLUS! Choose Between Two Tracks of Content:

  • Pricing & Contracting — for manufacturers
  • Part D Plan Strategies —a for health plans and PBMs

Download the Conference Preview

Medicare Pricing & Contracting Congress

Latest Policies and Reform Initiatives Impacting Pricing, Strategy, Quality and Transparency

The current Medicare and drug pricing landscape is facing the potential for seismic changes in the year ahead. CBI’s Medicare Pricing & Contracting Congress expands to convene stakeholders representing bio/pharma manufacturers, health plans, PBMs and leading policy advisors to provide critical updates and analysis on the impact of changing legislation. This conference provides in-depth analyses on critical topics including the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, Senate HELP Committee’s health care costs package, drug pricing bills, operationalizing value-based contracting, changes to the coverage gap and updates on the potential impacts of the International Pricing Index Model and the Most Favored-Nations Clause.

In-Depth Discussions on
High-Impact Issues, Including:

  • Political and legislative trends impacting coverage & access
  • International Pricing Index Model (IPI) and
    Most Favored-Nations Clause updates
  • Changes to Part B and ASP reporting requirements
  • Trends and insights into Medicare Part D drug spending
  • Key considerations for balancing care and quality
    while delivering patient-centric outcomes
  • Approaches for value-based contracting and
    alternative payment models

PLUS! Choose Between Two Tracks of Content:

  • Pricing & Contracting — for manufacturers
  • Part D Plan Strategies —a for health plans and PBMs

Download the Conference Preview